| Financial Year |
March 31 2023 |
| Monetary Funds |
423,561,655.56 |
| Held-for-trading Financial Assets |
64,000,000.00 |
| Notes Receivable |
12,567,265.16 |
| Accounts Receivable |
479,429,060.08 |
| Advances to Suppliers |
39,599,912.72 |
| Other Receivables |
26,769,111.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
64,602,605.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,087,152.41 |
| Total Current Assets |
1,435,297,657.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
143,311,827.21 |
| Investment Properties |
-- |
| Fixed Assetes |
32,352,403.03 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,570,304.28 |
| R&D expenses |
-- |
| Goodwill |
6,307,456.14 |
| Long-Term Deferred and Prepaid Expenses |
9,966,338.21 |
| Deferred Income Tax Assets |
44,695,300.71 |
| Other Non-Current Assets |
62,301,179.38 |
| Sub-Total of Non-Current Assets |
408,250,394.24 |
| Total Assets |
1,843,548,051.26 |
| Short-Term Loans |
115,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
86,153,261.17 |
| Accounts Payable |
298,537,181.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,913,604.57 |
| Taxes Payable |
49,132,355.90 |
| Interest Payable |
253,862.60 |
| Dividend Payable |
-- |
| Other payables |
4,071,308.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,696,252.03 |
| Other Current Liabilities |
9,582,426.87 |
| Sub-Total of Current Liabilities |
711,186,041.23 |
| Long-term Loans |
-- |
| Bonds Payable |
222,332,588.09 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
893,217.30 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
3,785,164.05 |
| Sub-Total of Non-Current Liabilities |
256,470,141.62 |
| Total Liabilities |
967,656,182.85 |
| Paid-In Capital(Or Share Stock) |
120,459,442.00 |
| Capital Surplus |
436,221,907.01 |
| Surplus Reserve |
28,334,895.83 |
| LESS:Treasury Stock |
763,499.92 |
| Undistributed Profits |
267,438,009.75 |
| Minority Stockholder's Interest |
-596,107.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
876,487,976.33 |
| Owner's Equity（Stockholder's Equity） |
875,891,868.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,843,548,051.26 |
